ArticleCardio-oncology (London, England)2025

Primary prevention of cardiotoxicity in cancer patients treated with fluoropyrimidines: a randomized controlled trial.

Johanne D Lyhne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.